Heart ultrasound in nursing homes could cut emergency stays
NCT ID NCT06445231
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will give heart ultrasounds to 1050 nursing home residents to see if catching heart problems early reduces flare-ups and unplanned hospital stays. Researchers will also check if the scans are practical and affordable for nursing homes. The goal is to improve heart care for older adults without sending them to the hospital.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- echocardiography (heart ultrasound)
- What this could lead to
- If successful, routine heart scans in nursing homes could catch heart problems early and reduce emergency hospital visits.
- What could go wrong
- This is an early implementation study, not a treatment trial. It may show no benefit in reducing hospitalizations, and results may not apply to all nursing homes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 1,050 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2024
- Expected to finish
-
Jan 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria : Nursing homes residents with a life-expectancy estimated \> 1 year, and able to participate to the study, giving an oral consent Exclusion Criteria : * no accessible to echocardiography * closed unit (severe Alzheimer disease…) * recent contagious disease such Covid (\<15 days) * no consent to participate * no social security number
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Nantes University Hospital
RECRUITINGNantes, Loire-Atlantique, 44093, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- Can better training get doctors to talk about what matters most to dying veterans?
- Can AI read heart ultrasounds as well as trained sonographers?
- Can modern heart failure drugs reverse damage in three months?